In 2017, Titan Medical launched a feasibility and validity study for it Sport Surgical System. Celebration-based Florida Hospital Nicholson Center and New York City-based Columbia University Medical Center are the two hospitals in the U.S. spearheading the device.
Here are five things to know:
1. Titan Medical’s research and development expenses for 2017 reached $12.90 million compared to $22.58 million in 2016.
2. In June 2017, Titan Medical completed a public offering for gross proceeds of $5.58 million followed by a second closing for an additional $1.33 million.
3. Titan Medical completed a private placement involving various robotic surgeons in the U.S. that grossed $2.68 million.
4. In December 2017, Titan Medical completed another public offering totaling $17.89 million.
5. At the end of the year, the company’s cash, cash equivalents and deposits with product development service providers reached $28.67 million, as compared to $6.36 million in 2016.
More articles on MIS:
Saint Anne’s Hospital launches Globus ExcelsiusGPS for minimally invasive spine surgery: 3 insights
7 top device companies in global minimally invasive spine surgery market
Spine surgeon Dr. Michael Halperin to speak on new minimally invasive procedure: 4 key points
